Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fitscha

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 1, 1988
Epoprostenol in patients with Raynaud's diseaseP Fitscha, J Kaliman, F Weidinger, et al.
Prostaglandins|August 1, 1996
Prostaglandin I2-mediated upregulation of 125I-LDL-receptor binding by isradipine in normo- and hypercholesterolemic rabbits in vivoH Sinzinger, G Lupattelli, H Kritz, et al.
Progress in Clinical and Biological Research|January 1, 1990
Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosisI Virgolini, C Müller, P Fitscha, et al.
Wiener Medizinische Wochenschrift (1946)|October 31, 1981
[Optimized sequential pacing of atrium and ventricle (author's transl]P Fitscha, H Kassal, A Laczkovics, et al.
Gerontology|January 1, 1982
Influence of smoking and age on pharmacokinetics of beta-receptor blockersG Hitzenberger, P Fitscha, T Beveridge, et al.
British Journal of Clinical Pharmacology|June 1, 1988
Stabilization of endothelial lining and decrease in circulating endothelial cells--one mechanism underlying the clinical action of PGE1?H Sinzinger, I Virgolini, P Fitscha, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.
Progress in Clinical and Biological Research|January 1, 1989
Calcium blockers: antiatherogenic action by influencing the prostaglandin-systemK Weiss, P Fitscha, A Gazsó, et al.
Prostaglandins|June 1, 1990
A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular diseaseI Virgolini, P Fitscha, O I Linet, et al.
Platelets|November 4, 2010
Influence of a single dose of calcium channel blockers on platelet functionK Weiss, P Fitscha, I Virgolini, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 1, 1988
Epoprostenol in patients with Raynaud's diseaseP Fitscha, J Kaliman, F Weidinger, et al.
Prostaglandins|August 1, 1996
Prostaglandin I2-mediated upregulation of 125I-LDL-receptor binding by isradipine in normo- and hypercholesterolemic rabbits in vivoH Sinzinger, G Lupattelli, H Kritz, et al.
Progress in Clinical and Biological Research|January 1, 1990
Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosisI Virgolini, C Müller, P Fitscha, et al.
Wiener Medizinische Wochenschrift (1946)|October 31, 1981
[Optimized sequential pacing of atrium and ventricle (author's transl]P Fitscha, H Kassal, A Laczkovics, et al.
Gerontology|January 1, 1982
Influence of smoking and age on pharmacokinetics of beta-receptor blockersG Hitzenberger, P Fitscha, T Beveridge, et al.
British Journal of Clinical Pharmacology|June 1, 1988
Stabilization of endothelial lining and decrease in circulating endothelial cells--one mechanism underlying the clinical action of PGE1?H Sinzinger, I Virgolini, P Fitscha, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.
Progress in Clinical and Biological Research|January 1, 1989
Calcium blockers: antiatherogenic action by influencing the prostaglandin-systemK Weiss, P Fitscha, A Gazsó, et al.
Prostaglandins|June 1, 1990
A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular diseaseI Virgolini, P Fitscha, O I Linet, et al.
Platelets|November 4, 2010
Influence of a single dose of calcium channel blockers on platelet functionK Weiss, P Fitscha, I Virgolini, et al.
Pageof 13